Disease: Protoporphyria
- A case of erythrogenic protoporphyria with thyrotoxicosis and liver dysfunction in an adult female
- A gel-forming α-MSH analog promotes lasting melanogenesis
- A Mysterious Abdominal Pain
- Absorption, metabolism, and excretion of [<sup>14</sup> C]dersimelagon, an investigational oral selective melanocortin 1 receptor agonist, in preclinical species and healthy volunteers
- Activation of the NLRP3 inflammasome by HMGB1 through inhibition of the Nrf2/HO-1 pathway promotes bleomycin-induced pulmonary fibrosis after acute lung injury in rats
- Afamelanotide
- Afamelanotide Is Associated with Dose-Dependent Protective Effect from Liver Damage Related to Erythropoietic Protoporphyria
- Cimetidine Does Not Inhibit 5-Aminolevulinic Acid Synthase or Heme Oxygenase Activity: Implications for Treatment of Acute Intermittent Porphyria and Erythropoietic Protoporphyria
- Comment on "Liver involvement in patients with erythropoietic protoporphyria"
- Consecutive Liver and Bone Marrow Transplantation for Erythropoietic Protoporphyria: Case Report and Literature Review
- Current trials in erythropoietic protoporphyria: are placebo controls ethical?
- Definitive Confirmation of Erythropoietic Protoporphyria via Re-biopsy Three Years After Initial Liver Biopsy at Age 15
- Dersimelagon in Erythropoietic Protoporphyrias
- Dersimelagon in Erythropoietic Protoporphyrias. Reply
- Development and content validation of a sunlight exposure diary in patients with erythropoietic protoporphyria
- Development and Content Validation of Novel Patient-Reported Outcome Measures to Assess Disease Severity and Change in Patients with Erythropoietic Protoporphyria: The EPP Impact Questionnaire (EPIQ)
- Diagnosis and management of protoporphyria-related liver dysfunction in erythropoietic protoporphyria and x-linked protoporphyria: A patient-friendly summary of the 2023 evidence-based consensus guidelines
- Edaravone dexborneol protects against cerebral ischemia/reperfusion-induced blood-brain barrier damage by inhibiting ferroptosis via activation of nrf-2/HO-1/GPX4 signaling
- Erythropoietic protoporphyria and afamelanotide: a patient's perspective
- Erythropoietic protoporphyria: case reports for clinical and therapeutic hints
- Evaluation of living donors for hereditary liver disease (siblings, heterozygotes)
- Evidence based consensus guidelines for diagnosis and management of Protoporphyria-Related liver dysfunction in erythropoietic protoporphyria and X-Linked protoporphyria
- Evidence-based consensus guidelines for the diagnosis and management of protoporphyria-related liver dysfunction in erythropoietic protoporphyria and X-linked protoporphyria
- Heme oxygenase-1 is an equid alphaherpesvirus 8 replication restriction host protein and suppresses viral replication via the PKCβ/ERK1/ERK2 and NO/cGMP/PKG pathway
- Hepatic farnesoid X receptor is necessary to facilitate ductular reaction and expression of heme biosynthetic genes
- Illuminating Dersimelagon: A Novel Agent in the Treatment of Erythropoietic Protoporphyria and X-Linked Protoporphyria
- Into the Light: Afamelanotide and the Treatment of Erythropoietic Protoporphyria in the United States
- Letter to the Editor: Contrasting effect of iron supplementation in protoporphyria
- Liver transplantation and primary liver cancer in porphyria
- Living-Donor Liver Transplantation for Erythropoietic Protoporphyria: A Case Report and Literature Review
- Management of erythropoietic protoporphyria with cholestatic liver disease: A case report
- Observational pilot study of multi-wavelength wearable light dosimetry for erythropoietic protoporphyria
- Peptide Conjugates of a 2'-<em>O</em>-Methoxyethyl Phosphorothioate Splice-Switching Oligonucleotide Show Increased Entrapment in Endosomes
- Photosensitivity
- Photosensitivity
- Porphyrias: Uncommon disorders masquerading as common childhood diseases
- Protoporphyrin IX-induced phototoxicity: Mechanisms and therapeutics
- Reply: Contrasting effect of iron supplementation in protoporphyria
- Targeting the central melanocortin system for the treatment of metabolic disorders
- The effects of cholecalciferol and afamelanotide on vitamin D levels in erythropoietic protoporphyria; a multicentre cohort study
- Update on the Porphyrias